Search details
1.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Eur Respir J
; 61(3)2023 03.
Article
in English
| MEDLINE | ID: mdl-36328357
2.
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians.
Respiration
; 102(2): 83-100, 2023.
Article
in English
| MEDLINE | ID: mdl-36516792
3.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Eur Respir J
; 54(6)2019 12.
Article
in English
| MEDLINE | ID: mdl-31601711
4.
A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
J Antimicrob Chemother
; 74(4): 935-943, 2019 04 01.
Article
in English
| MEDLINE | ID: mdl-30649327
5.
Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 Countries.
Ther Drug Monit
; 41(6): 714-718, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31169760
6.
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
Am J Respir Crit Care Med
; 198(3): 379-386, 2018 08 01.
Article
in English
| MEDLINE | ID: mdl-29509468
7.
Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease.
Antimicrob Agents Chemother
; 62(10)2018 10.
Article
in English
| MEDLINE | ID: mdl-30104268
8.
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.
Am J Respir Crit Care Med
; 191(9): 1058-65, 2015 May 01.
Article
in English
| MEDLINE | ID: mdl-25654354
9.
Multidrug-resistant tuberculosis in Europe, 2010-2011.
Emerg Infect Dis
; 21(3): 409-16, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25693485
10.
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
N Engl J Med
; 375(11): 1103-5, 2016 Sep 15.
Article
in English
| MEDLINE | ID: mdl-27626539
11.
Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease.
Eur Respir J
; 54(1)2019 07.
Article
in English
| MEDLINE | ID: mdl-31000680
12.
Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde?
Eur Respir J
; 54(1)2019 07.
Article
in English
| MEDLINE | ID: mdl-30956203
13.
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease.
Eur Respir J
; 54(1)2019 07.
Article
in English
| MEDLINE | ID: mdl-31000671
14.
Clofazimine does not lead to significant QT interval prolongation: a multicentre study.
Eur Respir J
; 52(5)2018 11.
Article
in English
| MEDLINE | ID: mdl-30385602
15.
Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.
Am J Respir Crit Care Med
; 196(9): 1222-1224, 2017 11 01.
Article
in English
| MEDLINE | ID: mdl-28323453
16.
The accuracy of an electronic nose to diagnose tuberculosis in patients referred to an expert centre.
PLoS One
; 18(2): e0276045, 2023.
Article
in English
| MEDLINE | ID: mdl-36749748
17.
Dried Blood Spot Sampling to Assess Rifampicin Exposure and Treatment Outcomes among Native and Non-Native Tuberculosis Patients in Paraguay: An Exploratory Study.
Pharmaceutics
; 15(4)2023 Mar 29.
Article
in English
| MEDLINE | ID: mdl-37111575
18.
Clofazimine Is a Safe and Effective Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
Chest
; 2023 Nov 29.
Article
in English
| MEDLINE | ID: mdl-38040054
19.
Treatment outcomes of MDR-TB and HIV co-infection in Europe.
Eur Respir J
; 49(6)2017 06.
Article
in English
| MEDLINE | ID: mdl-28596434
20.
Therapeutic drug monitoring in the treatment of tuberculosis patients.
Pulm Pharmacol Ther
; 25(1): 83-6, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22179055